About EvidScience
EvidScience is a Healthcare company based in El Segundo (United States) founded in 2016, and was acquired by Genesis Research in January 2021. Developer an ML platform for generating insights by analyzing pharma literature. EvidScience has raised $500 thousand across 2 funding rounds from investors including Tikehau Capital, Genesis Research and Wavemaker 360. Its focus areas include HealthTech, Life Sciences Tech, Diversified and Life Sciences. Its competitors include Veeva Systems, Instem and Strateos; 2 of its 3 listed competitors have raised funding.
Company details
EvidScience has developed a machine learning-based platform which can analyze data available in peer-reviewed articles to generate insights and summaries of cost and outcomes related data. The company claims that its platform can generate 500X faster than humans. The company can analyze data and provide outcomes with respect to brand insights, competitive landscapes, clinical study design optimization, and real-time cost analysis.
- Headquarters El Segundo, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website evidscience.com
- Social LinkedIn X
- Acquired by Genesis Research (Jan 2021)
- Total Equity Funding$500K (USD)
in 2 rounds
- InvestorsTikehau Capital
& 3 more
- Acquired byGenesis Research
(Jan 2021)
Funding Insights of EvidScience
EvidScience has successfully raised a total of $500K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $500,000
- Total Rounds 2
- First Round $500,000
(Feb 2018)
- Investors Count 3
All 2 funding rounds of EvidScience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2019 | Seed | – | Wavemaker 360, Mucker | – | |
| Feb 2018 | $500,000 | Seed | – | Tikehau Capital | – |
4 investors in total: 4 institutional.
Investors in EvidScience
EvidScience has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Tikehau Capital, Genesis Research and Wavemaker 360.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| wavemaker360.com | ||||
Accelerator and venture capital firm | mucker.com | Santa Monica, United States | ||
Debt and equity investments are managed by the private fund. | 2013 | tikehaucapital.com | London, United Kingdom | |
Research support is provided to the life science industry. | 2009 | genesisrg.com | Hoboken, United States |
Investor details for EvidScience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of EvidScience
4 dated milestones of EvidScience across 5 years, from founding to its latest funding, stage changes and deals.
- Founded EvidScience is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Seed,.
- Exit Acquired by Genesis Research.
Competitors of EvidScience
EvidScience has 3 listed competitors in our database, 2 of them funded. They include Veeva Systems, Instem and Strateos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| veeva.com | 2007 | Pleasanton, United States | $4M | 226 | Cloud-based data management solutions for healthcare are provided. | |
| instem.com | 1969 | Conshohocken, United States | 190 | Software for life science data collection and analysis is provided. | ||
| strateos.com | 2019 | Menlo Park, United States | $72.6M | 147 | Provider of cloud based platform provides data driven information for biotech research |
Detailed competitors of EvidScience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as EvidScience (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Evidscience
Complete news archive for EvidScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EvidScience
EvidScience was founded in 2016 and raised its 1st funding round 2 years after it was founded.
EvidScience is headquartered in El Segundo, United States. It is registered at El Segundo, California, United States.
EvidScience is a funded company, having raised a total of $500K across 2 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Feb 2018.
EvidScience has developed a machine learning-based platform which can analyze data available in peer-reviewed articles to generate insights and summaries of cost and outcomes related data. The company claims that its platform can generate 500X faster than humans. The company can analyze data and provide outcomes with respect to brand insights, competitive landscapes, clinical study design optimization, and real-time cost analysis.
EvidScience's top competitors include Veeva Systems, Instem and Strateos.
EvidScience has 4 investors. Key investors include Tikehau Capital, Genesis Research, Wavemaker 360, and Mucker.
Yes. EvidScience was acquired by Genesis Research in January 2021.